Advertisement
Screener

AirSculpt Technologies, Inc. (AIRS) EBITDA

AirSculpt Technologies, Inc. (AIRS) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $2.91M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA $1.22M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $2.07M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$6.53M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$2.91M(m)(m)(m)6.79%$228.00K*-$1.24M*(m)(m)$23.42M-$101.00K
2026-03-31Reported$1.22M(m)(m)(m)3.09%$51.00K$5.27M(m)(m)$22.58M-$465.00K
2025-12-31Reported$2.07M(m)(m)(m)6.19%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$6.53M(m)(m)(m)-18.67%$180.00K*-$225.00K*(m)(m)$19.52M-$1.65M
2025-06-30Reported$4.03M(m)(m)(m)9.16%$265.00K*$4.98M*(m)(m)$22.67M-$185.00K
2025-03-31Reported$1.65M(m)(m)(m)4.20%$1.90M$868.00K(m)(m)$21.77M-$367.00K
2024-12-31Reported-$703,000.00(m)(m)(m)-1.79%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$713,000.00(m)(m)(m)-1.68%$4.90M*$1.83M*(m)(m)$25.50M$733.00K
2024-06-30Reported-$2.1M(m)(m)(m)-4.11%$4.02M*$3.44M*(m)(m)$34.27M-$3.29M
2024-03-31Reported$13.82M(m)(m)(m)29.02%$1.56M$3.37M(m)(m)$15.76M$3.45M
2023-12-31Reported$4.42M(m)(m)(m)9.28%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$3.58M(m)(m)(m)7.66%$2.12M*$635.00K*(m)(m)$25.03M$786.00K
2023-06-30Reported$7.88M(m)(m)(m)14.14%$2.16M*$12.24M*(m)(m)$27.89M$1.70M
2023-03-31Reported$4.1M(m)(m)(m)8.95%$3.81M$6.22M(m)(m)$23.88M$41.00K
2022-12-31Reported-$3.74M(m)(m)(m)-9.20%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$619,000.00(m)(m)(m)1.59%$4.59M*$329.00K*(m)(m)$23.40M$4.23M
2022-06-30Reported$5.93M(m)(m)(m)11.93%$1.86M*$10.40M*(m)(m)$26.01M$1.82M
2022-03-31Reported$715,000.00(m)(m)(m)1.81%$4.27M$7.08M(m)(m)$24.17M-$1.97M
2021-12-31Reported-$10.32M(m)(m)(m)-27.49%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$11.26M(m)(m)(m)32.50%$1.58M*$8.53M*(m)(m)$11.98M$0.00
2021-06-30Reported$12.73M(m)(m)(m)36.41%$1.56M*$14.64M*(m)(m)$10.33M$0.00
2021-03-31Reported$8.7M(m)(m)(m)33.27%$1.59M$9.18M(m)(m)$8.66M$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$1.22M(m)(m)(m)0.80%$2.40M$3.10M(m)(m)$82.18M-$5.97M
2024-12-31Reported$10.31M(m)(m)(m)5.71%$14.01M$11.35M(m)(m)$98.88M$188.00K
2023-12-31Reported$19.98M(m)(m)(m)10.20%$9.92M$23.96M(m)(m)$102.38M$7.48M
2022-12-31Reported$3.52M(m)(m)(m)2.08%$12.92M$24.45M(m)(m)$101.42M$3.38M
2021-12-31Reported$22.37M(m)(m)(m)16.78%$7.12M$26.63M(m)(m)$65.73M$329.00K
2020-12-31Reported$15.67M(m)(m)(m)24.97%$3.69M$13.96M(m)(m)$23.62M$0.00
2019-12-31Reported$5.62M(m)(m)(m)13.64%$4.44M$4.94M(m)(m)$20.13M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
LifeMD, Inc. (LFMD)United States$0.141B982.53
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Teladoc Health, Inc. (TDOC)United States$1.114B-8.68